News Archives
- 2013-03-12 - Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
- 2013-02-18 - Stories your Patients May be Talking About: Targeted Cancer Drugs Keep Myeloma Patients Up And Running - NPR
- 2013-02-08 - NEWS FLASH...FDA approves Pomalidomide (Pomalyst) for advanced multiple myeloma
- 2013-01-23 - New Research May Aid Treatment in Multiple Myeloma Patients
- 2012-12-04 - The Multiple Myeloma Research Foundation (MMRF) and GenoSpace Partner to Launch Groundbreaking Information Ecosystem -- MMRF News Release
- 2012-10-03 - NextBio, Emory University partner to identify biomarkers and treatments for cancer patients -- Pharmabiz.com
- 2012-10-03 - Celgene Corporation Provides Update on FDA Advisory Committee for Pomalidomide -- DailyFinance
- 2012-10-02 - Janssen-Cilag receives authorization for multiple myeloma treatment in Europe
- 2012-10-02 - The Multiple Myeloma Drug Market Will Experience Significant Growth, Increasing from $4.4 Billion in 2011 to $7.2 Billion in 2021 -- Market Watch:The Wall Street Journal
- 2012-10-01 - Researchers harness the immune system to improve stem cell transplant outcomes
- 2012-09-08 - Balloons Carve Spot in Myeloma Spine Disease - IMNE
- 2012-08-16 - Novel Therapeutic Approach to Cancer Treatment: Senesco completes first cohort of patients in Phase 1b/2a multiple myeloma trial -- PBR
- 2012-08-15 - Longtime biotech exec Richard Brewer dies from multiple myeloma--San Francisco Business Times
- 2012-08-14 - Scientists devise new strategy to destroy multiple myeloma -- Science Codex
- 2012-08-06 - Cancer Patients Differ With Docs on QoL Issues- The Oncology Report